英文名 | 3-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]benzoic acid |
---|---|
英文别名 |
3-[(1-{[(1,1-dimethylethyl)oxy]carbonyl}-4-piperidinyl)methyl]benzoic acid
3-[(1-Boc-4-piperidinyl)methyl]benzoic acid 3-[(1-{[(1,1-dimethyIethyl)oxy]carbonyl}-4-piperidinyl)methyl]benzoic acid 3-((1-(tert-Butoxycarbonyl)piperidin-4-yl)methyl)benzoic acid |
分子式 | C18H25NO4 |
---|---|
分子量 | 319.39500 |
精确质量 | 319.17800 |
PSA | 66.84000 |
LogP | 3.51230 |
海关编码 | 2933399090 |
---|
~% 799283-53-7 |
文献:AVENTIS PHARMACEUTICALS INC. Patent: WO2004/100946 A1, 2004 ; Location in patent: Page 54 ; WO 2004/100946 A1 |
上游产品 1 | |
---|---|
下游产品 0 |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |